Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.

Miura, Y; Ueda, M; Takami, A; Shiobara, S; Nakao, S; Hess, A D

Miura, Y; Ueda, M; Takami, A; Shiobara, S; Nakao, S; Hess, A D.

Affiliation

Miura Y; The Sidney Kimmel Cancer Research Center at Johns Hopkins University, Baltimore, MD 21231, USA. ymiura@jhmi.edu

Bone Marrow Transplant ; 32(8): 785-90, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14520422

Subject(s)

Cyclosporine/adverse effects; Graft vs Host Disease/chemically induced; Hematopoietic Stem Cell Transplantation/adverse effects; Hematopoietic Stem Cells/cytology; Immunosuppressive Agents/adverse effects; Antigens, CD34/analysis; Antineoplastic Agents/adverse effects; Cell Separation; Female; Graft vs Host Disease/mortality; Hematopoietic Stem Cell Transplantation/mortality; Hematopoietic Stem Cells/chemistry; Humans; Interferon-gamma/adverse effects; Male; Middle Aged

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Cyclosporine / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Immunosuppressive Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2003 Document type: Article

Search on Google

XML

PubMed Links